November 30, 2021
[Moscow – 30.11.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the launch of its new website, https://insysbio.com/. The aim of redesign was to fully represent all InSysBio’s diversified experience and to reflect the company’s current trend. The new website is more structured, user-friendly and provides more opportunities for feedback.
Thus, InSysBio’s new website embraces Blog as one of fundamental new features. It should be outlined that its core idea is to provide a unique collection of methodological materials on QSP modeling that has no analogue. Moreover, the company’s website has undergone rebranding to declare the corporate philosophy. Now it presents InSysBio’s brand identity and main principles through the statement of its mission, vision, and values.
To start with, InSysBio can be well-deservedly called the pioneer of QSP modeling since it goes back to 2004 with the year of its foundation. InSysBio has been constantly tracking the purpose of сutting costs and risks of time-demanding process of drug development. InSysBio’s full concept of functioning aims at three main interdependent components: our partners, drug development process and patients. This chain has become the platform for the mission statement – “At InSysBio our mission is to provide QSP-modeling to world pharma to assist in efficient drug development thus bringing hope to patients”.
InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners (there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry). But still we see the potential to grow beyond this horizon and the vision statement emerges from this idea – “Our vision is to establish QSP-modeling as an essential part of pharmaceutical industry in order to dramatically reduce risks and time consumption of drug development cycle”.
Besides these directions, we undertake efforts to contribute to our corporate and global researching environment. All our commitment towards our key-audiences and corporate philosophy are covered by our values. In total, the entire concept can be briefly expressed by our slogan "Building models – Bringing hope".
About InSysBio
InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.
← | October 2024 | → | ||||
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1
|
2
|
3
|
4
1.
04 Oct 2024 16:13
InSysBio to participate in SITC 2024
InSysBio announces its participation in SITC’s 39th Annual Meeting which is to be held from November 6-10, 2024, at George R. Brown Convention Center in Houston, TX, USA. InSysBio team is going to present its Mechanistic modeling services and tools to support development of immunotherapies at Booth #1032 and 3 posters in frames of the Meeting
|
5
|
6
| |
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
1.
16 Oct 2024 19:36
InSysBio to take part in "An Introduction to QSP" event
InSysBio announces its participation in An Introduction to QSP, A UK QSP Network hybrid (in person/online) event which is to be held 17-20hrs 24th October 2024. Oleg Demin Jr, Scientific Director, Oncology & Immuno-Oncology, will discuss the prediction of the first-in-human dose for T-cell engagers using mechanistic modelling
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|